162 related articles for article (PubMed ID: 24977435)
21. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.
Flores-Villanueva PO; Yunis EJ; Delgado JC; Vittinghoff E; Buchbinder S; Leung JY; Uglialoro AM; Clavijo OP; Rosenberg ES; Kalams SA; Braun JD; Boswell SL; Walker BD; Goldfeld AE
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5140-5. PubMed ID: 11309482
[TBL] [Abstract][Full Text] [Related]
22. [The favorable effects of KIR3DS1 and Bw4(80Ile) on viral set point and CD4 count decline in HIV-1 patients with acutely infected with HIV-1 infection].
Wang R; Liu Y; Lu XF; Liu ZY; Li Z; Zhang X
Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(35):2819-2823. PubMed ID: 30248785
[No Abstract] [Full Text] [Related]
23. Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6.
Müller CA; Engler-Blum G; Gekeler V; Steiert I; Weiss E; Schmidt H
Immunogenetics; 1989; 30(3):200-7. PubMed ID: 2777338
[TBL] [Abstract][Full Text] [Related]
24. Mapping of an epitope defined by a human hybridoma antibody (TrD3): a new HLA-B supertype associated with a subset of HLA-Bw6.
Kolstad A; Toubert A; Weyl D; Jun G; Hannestad K
Hum Immunol; 1992 Jun; 34(2):77-84. PubMed ID: 1385373
[TBL] [Abstract][Full Text] [Related]
25. Association of Bw4/Bw6 mismatch across class I HLA loci with renal graft outcomes in first time transplants.
Tang MS; Wang M; Chang SH; Alhamad T; Liu C
Hum Immunol; 2021 Oct; 82(10):767-774. PubMed ID: 34362574
[TBL] [Abstract][Full Text] [Related]
26. Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B.
Thananchai H; Gillespie G; Martin MP; Bashirova A; Yawata N; Yawata M; Easterbrook P; McVicar DW; Maenaka K; Parham P; Carrington M; Dong T; Rowland-Jones S
J Immunol; 2007 Jan; 178(1):33-7. PubMed ID: 17182537
[TBL] [Abstract][Full Text] [Related]
27. The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes.
Wan AM; Ennis P; Parham P; Holmes N
J Immunol; 1986 Dec; 137(11):3671-4. PubMed ID: 2431040
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a monoclonal anti-Bw4 antibody (Tü109): evidence for similar epitopes on the Bw4 and Bw6 antigens.
Müller C; Herbst H; Uchanska-Ziegler B; Ziegler A; Schunter F; Steiert I; Muller C; Wernet P
Hum Immunol; 1985 Dec; 14(4):333-49. PubMed ID: 2416720
[TBL] [Abstract][Full Text] [Related]
29. KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma.
Forlenza CJ; Boudreau JE; Zheng J; Le Luduec JB; Chamberlain E; Heller G; Cheung NK; Hsu KC
J Clin Oncol; 2016 Jul; 34(21):2443-51. PubMed ID: 27069083
[TBL] [Abstract][Full Text] [Related]
30. The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations.
Foley BA; De Santis D; Van Beelen E; Lathbury LJ; Christiansen FT; Witt CS
Blood; 2008 Jul; 112(2):435-43. PubMed ID: 18385451
[TBL] [Abstract][Full Text] [Related]
31. HLA Mismatching Favoring Host-Versus-Graft NK Cell Activity Via KIR3DL1 Is Associated With Improved Outcomes Following Lung Transplantation.
Greenland JR; Sun H; Calabrese D; Chong T; Singer JP; Kukreja J; Hays SR; Golden JA; Caughey GH; Venstrom JM; Rajalingam R
Am J Transplant; 2017 Aug; 17(8):2192-2199. PubMed ID: 28375571
[TBL] [Abstract][Full Text] [Related]
32. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.
Parsons MS; Wren L; Isitman G; Navis M; Stratov I; Bernard NF; Kent SJ
J Virol; 2012 Apr; 86(8):4488-95. PubMed ID: 22345455
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
Maruthamuthu S; Rajalingam R; Pandian K; Madasamy S; Manoharan M; Pitchai L; Murugesan A; Mariakuttikan J
AIDS; 2018 Nov; 32(18):2679-2688. PubMed ID: 30289808
[TBL] [Abstract][Full Text] [Related]
34. A public HLA antigen associated with HLA-A9, Aw32, and Bw4.
Kostyu DD; Cresswell P; Amos DB
Immunogenetics; 1980; 10(5):433-42. PubMed ID: 22457917
[TBL] [Abstract][Full Text] [Related]
35. Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes.
Tallon BJ; Bruneau J; Tsoukas CM; Routy JP; Kiani Z; Tan X; Bernard NF
PLoS One; 2014; 9(10):e110480. PubMed ID: 25330014
[TBL] [Abstract][Full Text] [Related]
36. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80.
Cella M; Longo A; Ferrara GB; Strominger JL; Colonna M
J Exp Med; 1994 Oct; 180(4):1235-42. PubMed ID: 7931060
[TBL] [Abstract][Full Text] [Related]
37. HLA-A alleles influencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantation.
van der Ploeg K; Le Luduec JB; Stevenson PA; Park S; Gooley TA; Petersdorf EW; Shaffer BC; Hsu KC
Blood Adv; 2020 Oct; 4(19):4955-4964. PubMed ID: 33049053
[TBL] [Abstract][Full Text] [Related]
38. Mind the gap: lack of association between KIR3DL1*004/HLA‐Bw4-induced natural killer cell function and protection from HIV infection.
Parsons MS; Boulet S; Song R; Bruneau J; Shoukry NH; Routy JP; Tsoukas CM; Bernard NF
J Infect Dis; 2010 Nov; 202 Suppl 3():S356-60. PubMed ID: 20887224
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a new HLA-B18 allele, B*1806, which lacks expression of the Bw6 epitope.
Balas A; García-Sánchez F; Santos S; Lillo R; Merino JL; Vicario JL
Tissue Antigens; 1998 Dec; 52(6):579-82. PubMed ID: 9894858
[TBL] [Abstract][Full Text] [Related]
40. In vitro education of human natural killer cells by KIR3DL1.
Pugh J; Nemat-Gorgani N; Djaoud Z; Guethlein LA; Norman PJ; Parham P
Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31723004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
